Eli Lilly and Company - Price To Sales Ratio

Eli Lilly and Company's Fiscal Year is From January To December.

The item "Price-To-Sales-Ratio" stands at 9.98 as of 09/30/2025, the lowest value since 12/31/2022.

As of the end of Eli Lilly and Company's third quarter, the item "Price To Sales Ratio" stands at 9.98. This represents a decrease of -19.45 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -44.88 percent compared to the value the year prior.
The 1 year change in percent is -44.88.
The 3 year change in percent is 3.62.

The Serie's long term average value is 13.18. It's latest available value, on 09/30/2025, is 24.28 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +20.06%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -49.00%.